BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, June 3, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 13, 2019
View Archived Issues
Phosphorylation of DLC1 by SRC and ERK decreases its tumor suppressor functions
Read More
1,18-Octodecanedioc acid conjugated to paclitaxel is active in complex with human serum albumin
Read More
Novel variants in WDR37 gene underlie a new syndromic neurological disorder
Read More
New MEK inhibitor URML-3881 potentiates cisplatin efficacy in CCOC
Read More
Good news, bad news macrophages identified in arthritis
Read More
MAbs can be smuggled past BBB
Read More
Interim data reported from phase I study of DS-Cav1 vaccine
Read More
Xiangbei Welman Pharmaceutical describes compounds for gout, hyperuricemia
Read More
Shanghai Yingli Pharmaceutical patents TGFR-1 inhibitors
Read More
Mu-opioid receptor agonists discovered at Sichuan Kelun-Biotech Biopharmaceutical
Read More
Inhibition of mitoNEET shows antileukemic activity in drug-resistant cells and in vivo models
Read More
FDA grants accelerated approval for bedaquiline in adolescents with MDR-TB
Read More
PALM Ebola study stopped early due to favorable results for two of four candidates
Read More
TR-FRET-based screening identifies novel CBP bromodomain inhibitor with therapeutic potential
Read More
Oncologie and Merck & Co. to test bavituximab plus Keytruda in gastric cancer
Read More
Basilea initiates phase I/II FIDES-02 study of derazantinib in urothelial cancer
Read More
Study finds best tools for pinpointing genetic disease drivers
Read More
Interim data from phase Ib study of KPL-716 supports phase II development
Read More
Deciphera Pharmaceuticals presents new clinical data for ripretinib in patients with GIST
Read More
Positive interim data presented from first in human study of TERN-201 in NASH
Read More
